143: Articular Chondrocalcinosis



Key Points







  • Disease summary:




    • The diagnostic for calcium pyrophosphate dihydrate (CPPD) crystal deposition is given after the identification of CPPD crystals in synovial fluid (SF) or in tissue sections.



    • The terminology of CPPD-related diseases is still not uniform; the following definitions are the most commonly used:




      • Pseudogout—acute clinical syndrome of synovitis associated with CPPD deposition



      • Pyrophosphate arthropathy—structural abnormality of cartilage and bone associated with articular CPPD deposition



      • Chondrocalcinosis (CC)—radiographic observation of calcification of fibro and/or hyaline articular cartilage



    • CPPD deposition is the main cause of radiographic articular calcification of the knee, that is, CC. The deposition of other calcium salts, such as hydroxyapatite, can also be the cause of articular calcification.



  • Hereditary basis:




    • CPPD deposition disease (CPDD) can occur as a familial monogenic disorder showing an autosomal dominant pattern of inheritance.



  • Differential diagnosis:




    • Certain metabolic diseases predispose to CPDD deposition such as hemochromatosis, Gitelman syndrome, and hyperparathyroidism. It is possible to screen these disorders by laboratory hematologic testing and evaluate elevated serum calcium, decreased serum phosphate, elevated parathyroid hormone or parathormone, elevated alkaline phosphatase, and increased serum ferritin. However, it is important to refer that these disorders have strong genetic component themselves. In Table 143-1, it is possible to see how to perform a genetic differential diagnosis.





Table 143-1   Genetic Differential Diagnosis 






Diagnostic Criteria and Clinical Characteristics





Diagnostic Criteria



At least two of the following





  • Demonstration of calcium pyrophosphate crystal deposition in tissue or SF by definitive means.



  • Identification of crystals showing weakly or no positive birefringence by compensated polarized light microscopy.



  • Presence of typical radiographic calcifications.



  • Acute arthritis, especially of knees or other large joints.



  • Chronic arthritis, especially of knee, hip, carpus elbow, shoulder, or metacarpophalangeal (MCP) joint, especially if accompanied by acute exacerbation; the chronic arthritis shows the following features, which are helpful in differentiating it from osteoarthritis:




    • Uncommon sites: wrist, MCP joint, elbow, shoulder



    • Radiographic—or patellofemoral joint-space narrowing, especially if isolated



    • Subchondral cyst formation



    • Severity of degeneration—progressive, with subchondral bony collapse and fragmentation with formation of intra-articular radiodense bodies



    • Osteophyte formation—variable and inconsistent



    • Tendon calcifications, especially triceps, Achilles, obturators




Categories





  • Definite disease: I or IIa and IIb must be fulfilled



  • Probable disease: IIa or IIb must be fulfilled



  • Possible disease: IIIa or IIIb should alert the clinician to the possibility of underlying calcium pyrophosphate deposition




Clinical Characteristics



CPPD-CC is clinically heterogeneous, including





  1. An asymptomatic presentation, common in elderly people, affecting mainly the knee by the deposition of CPPD crystals in articular hyaline and fibrocartilage (CC)


    An acute form of CPPD arthropathy, known as pseudogout

    Only gold members can continue reading. Log In or Register to continue

    Stay updated, free articles. Join our Telegram channel

Jun 2, 2016 | Posted by in HUMAN BIOLOGY & GENETICS | Comments Off on 143: Articular Chondrocalcinosis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access